vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与ROKU, INC（ROKU）财务数据对比。点击上方公司名可切换其他公司
ROKU, INC的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的1.7倍（$1.2B vs $749.2M），CLOVER HEALTH INVESTMENTS, CORP.净利率更高（3.6% vs -2.2%，领先5.8%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（62.0% vs -18.3%），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（45.0% vs 13.6%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
Roku是美国流媒体技术企业，2002年由安东尼·伍德创立，主营数字媒体播放器、电视硬件生产，流媒体内容分发及平台广告运营。截至2024年覆盖用户达1.45亿，是美国流媒体视频分发领域的市场领导者，业务覆盖澳、加、法、德、英及拉美多国。
CLOV vs ROKU — 直观对比
营收规模更大
ROKU
是对方的1.7倍
$749.2M
营收增速更快
CLOV
高出80.3%
-18.3%
净利率更高
CLOV
高出5.8%
-2.2%
两年增速更快
CLOV
近两年复合增速
13.6%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $749.2M | $1.2B |
| 净利润 | $27.3M | $-27.4M |
| 毛利率 | — | 35.6% |
| 营业利润率 | 3.6% | 59.7% |
| 净利率 | 3.6% | -2.2% |
| 营收同比 | 62.0% | -18.3% |
| 净利润同比 | — | -361.0% |
| 每股收益（稀释后） | $0.05 | $0.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVROKU
| Q1 26 | $749.2M | $1.2B | ||
| Q4 25 | $487.7M | $1.4B | ||
| Q3 25 | $496.6M | $1.2B | ||
| Q2 25 | $477.6M | $1.1B | ||
| Q1 25 | $462.3M | $1.0B | ||
| Q4 24 | $337.0M | $1.2B | ||
| Q3 24 | $331.0M | $1.1B | ||
| Q2 24 | $356.3M | $968.2M |
净利润CLOVROKU
| Q1 26 | $27.3M | $-27.4M | ||
| Q4 25 | $-49.3M | $80.5M | ||
| Q3 25 | $-24.4M | $24.8M | ||
| Q2 25 | $-10.6M | $10.5M | ||
| Q1 25 | $-1.3M | $-27.4M | ||
| Q4 24 | $-22.1M | $-35.5M | ||
| Q3 24 | $-9.2M | $-9.0M | ||
| Q2 24 | $7.4M | $-34.0M |
毛利率CLOVROKU
| Q1 26 | — | 35.6% | ||
| Q4 25 | — | 43.5% | ||
| Q3 25 | — | 43.4% | ||
| Q2 25 | — | 44.8% | ||
| Q1 25 | — | 43.6% | ||
| Q4 24 | — | 42.7% | ||
| Q3 24 | 24.5% | 45.2% | ||
| Q2 24 | 30.3% | 43.9% |
营业利润率CLOVROKU
| Q1 26 | 3.6% | 59.7% | ||
| Q4 25 | -10.1% | 4.7% | ||
| Q3 25 | -4.9% | 0.8% | ||
| Q2 25 | -2.2% | -2.1% | ||
| Q1 25 | -0.3% | -5.7% | ||
| Q4 24 | -6.4% | -3.3% | ||
| Q3 24 | -2.7% | -3.4% | ||
| Q2 24 | 2.0% | -7.4% |
净利率CLOVROKU
| Q1 26 | 3.6% | -2.2% | ||
| Q4 25 | -10.1% | 5.8% | ||
| Q3 25 | -4.9% | 2.0% | ||
| Q2 25 | -2.2% | 0.9% | ||
| Q1 25 | -0.3% | -2.7% | ||
| Q4 24 | -6.6% | -3.0% | ||
| Q3 24 | -2.8% | -0.9% | ||
| Q2 24 | 2.1% | -3.5% |
每股收益（稀释后）CLOVROKU
| Q1 26 | $0.05 | $0.57 | ||
| Q4 25 | — | $0.55 | ||
| Q3 25 | — | $0.16 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $-0.19 | ||
| Q4 24 | — | $-0.24 | ||
| Q3 24 | — | $-0.06 | ||
| Q2 24 | — | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.6M | $2.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $339.4M | $2.7B |
| 总资产 | $697.7M | $4.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLOVROKU
| Q1 26 | $177.6M | $2.4B | ||
| Q4 25 | $78.3M | $2.3B | ||
| Q3 25 | — | $2.3B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | $194.5M | $2.2B | ||
| Q3 24 | $288.0M | $2.1B | ||
| Q2 24 | $254.8M | $2.1B |
股东权益CLOVROKU
| Q1 26 | $339.4M | $2.7B | ||
| Q4 25 | $308.7M | $2.7B | ||
| Q3 25 | $340.9M | $2.6B | ||
| Q2 25 | $344.2M | $2.6B | ||
| Q1 25 | $336.1M | $2.5B | ||
| Q4 24 | $341.1M | $2.5B | ||
| Q3 24 | $342.2M | $2.5B | ||
| Q2 24 | $324.9M | $2.4B |
总资产CLOVROKU
| Q1 26 | $697.7M | $4.4B | ||
| Q4 25 | $541.0M | $4.4B | ||
| Q3 25 | $559.7M | $4.4B | ||
| Q2 25 | $575.0M | $4.3B | ||
| Q1 25 | $583.7M | $4.2B | ||
| Q4 24 | $580.7M | $4.3B | ||
| Q3 24 | $653.0M | $4.3B | ||
| Q2 24 | $674.2M | $4.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $199.1M |
| 自由现金流经营现金流 - 资本支出 | — | $298.4M |
| 自由现金流率自由现金流/营收 | — | 23.9% |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $640.0M |
8季度趋势，按日历期对齐
经营现金流CLOVROKU
| Q1 26 | — | $199.1M | ||
| Q4 25 | $-66.9M | $107.7M | ||
| Q3 25 | $12.1M | $127.6M | ||
| Q2 25 | $5.4M | $109.7M | ||
| Q1 25 | $-16.3M | $138.7M | ||
| Q4 24 | $34.8M | $79.3M | ||
| Q3 24 | $50.0M | $68.7M | ||
| Q2 24 | $44.8M | $23.4M |
自由现金流CLOVROKU
| Q1 26 | — | $298.4M | ||
| Q4 25 | $-69.0M | $106.6M | ||
| Q3 25 | $11.4M | $126.5M | ||
| Q2 25 | $4.8M | $108.6M | ||
| Q1 25 | $-16.5M | $136.8M | ||
| Q4 24 | $33.3M | $76.8M | ||
| Q3 24 | $49.6M | $67.6M | ||
| Q2 24 | $44.4M | $22.5M |
自由现金流率CLOVROKU
| Q1 26 | — | 23.9% | ||
| Q4 25 | -14.1% | 7.6% | ||
| Q3 25 | 2.3% | 10.4% | ||
| Q2 25 | 1.0% | 9.8% | ||
| Q1 25 | -3.6% | 13.4% | ||
| Q4 24 | 9.9% | 6.4% | ||
| Q3 24 | 15.0% | 6.4% | ||
| Q2 24 | 12.5% | 2.3% |
资本支出强度CLOVROKU
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 0.1% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.1% | 0.1% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.5% | 0.2% | ||
| Q3 24 | 0.1% | 0.1% | ||
| Q2 24 | 0.1% | 0.1% |
现金转化率CLOVROKU
| Q1 26 | — | — | ||
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 5.14× | ||
| Q2 25 | — | 10.45× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
ROKU
| Advertising | $612.7M | 49% |
| Subscriptions | $518.5M | 42% |
| Devices | $117.6M | 9% |
